Clinical chorioamnionitis at term VII: the amniotic fluid cellular immune response

Alicia Martinez-Varea1, Roberto Romero1, Yi Xu1

  • 1, NICHD/NIH/DHHS, Bethesda, MD, USA.

Insights

Chorioamnionitis involves increased neutrophils and monocytes in amniotic fluid, with distinct cytokine profiles. This study characterizes these immune cells and their inflammatory cytokine production in intra-amniotic infections.

Area of Science:

  • Obstetrics and Gynecology
  • Immunology
  • Perinatology

Background:

  • Clinical chorioamnionitis is a pregnancy complication often linked to intra-amniotic infection.
  • Understanding the immune response within the amniotic fluid is crucial for managing this condition.

Purpose of the Study:

  • To analyze the cellular composition of amniotic fluid in term patients with clinical chorioamnionitis.
  • To characterize cytokine production by amniotic fluid white blood cells using flow cytometry.

Main Methods:

  • Amniotic fluid samples from 20 women with clinical chorioamnionitis were analyzed.
  • Cultivation techniques identified microorganisms; flow cytometry assessed leukocyte immunophenotyping and cytokine expression.

Main Results:

  • Neutrophils and monocytes were the predominant leukocytes in amniotic fluid.
  • Higher neutrophil and monocyte counts were observed in patients with detectable microorganisms.
  • Differential cytokine production was noted: neutrophils produced TNF-α and MIP-1β, while monocytes produced IL-1β and IL-1α.

Conclusions:

  • Neutrophils and monocytes are key immune cells in the amniotic fluid during intra-amniotic infection associated with chorioamnionitis.
  • This study provides the first characterization of differential cytokine expression by these cells in this pregnancy complication.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
85.4K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
85.7K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
17.9K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.8K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.4K